BioWorld-International-2009-09-30
Qiagen's $130M Purchase of DxS a 13X Profit for Investors
Qiagen's $130M Purchase of DxS a 13X Profit for Investors
LONDON - There was a record return for all the investors in companion diagnostics pioneer DxS Ltd., when the company was acquired last week by Qiagen NV for a total of up to $130 million. (BioWorld International)

